Capricor Therapeutics, Inc.
CAPR
$6.39
-$0.21-3.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -135.56% | -149.04% | -833.81% | -96.49% | -49.32% |
| Total Depreciation and Amortization | 36.26% | 22.36% | 22.14% | 30.63% | 40.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.43% | 80.42% | 29.17% | 18.52% | 32.90% |
| Change in Net Operating Assets | 144.14% | 136.48% | 19.58% | 66.21% | 3.31% |
| Cash from Operations | -63.75% | -407.21% | -27.62% | -32.38% | -30.48% |
| Capital Expenditure | -1,691.97% | -71.65% | -0.75% | 90.66% | 65.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.28% | 383.23% | -2,289.19% | -75.29% | 120.71% |
| Cash from Investing | -0.99% | 351.43% | -2,004.52% | -74.04% | 127.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.05% | -97.80% | 250.01% | 30,350.88% | -5.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.05% | -97.80% | 250.01% | 30,350.88% | -5.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.13% | 306.45% | -1,099.80% | 6,867.04% | 682.21% |